Global Parkinson's Disease Epidemiology Market - Strategic Insights and Forecasts (2026-2035)

The global Parkinson’s disease epidemiology market is projected to register a strong CAGR during the forecast period from 2026 to 2035, driven by population aging, improving diagnostic awareness, rising survival rates, and expanding access to specialized neurological care.

Key challenges include limited access to neurologists in underserved regions, absence of definitive early-stage biomarkers, high long-term treatment costs, caregiver burden, and increasing pressure on healthcare systems.

Wearable devices, remote monitoring systems, and digital rehabilitation platforms are improving longitudinal disease tracking, treatment personalization, and remote patient management, enhancing care efficiency and patient monitoring.

Parkinson’s disease affects mobility, cognition, speech, swallowing, and daily functioning. Integrated care involving neurologists, physiotherapists, occupational therapists, speech therapists, and mental health specialists improves treatment adherence and quality of life.

North America represents one of the largest markets due to advanced healthcare infrastructure, widespread neurological specialist access, strong disease awareness, and extensive epidemiological surveillance programs.